AIXN vs CVS
Aixin Life International, Inc. and CVS Health Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | AIXN | CVS |
|---|---|---|
| Revenue | $1.5M | $402.1B |
| Net income | $-2.0M | $1.8B |
| Gross margin | 41.7% | 45.0% |
| Net margin | −137.1% | 0.4% |
| Return on equity | −227.3% | 2.3% |
| Diluted EPS | −$0.08 | $1.39 |
| Dividend / share | — | $2.66 |
| Payout ratio | — | 192.1% |
| Free cash flow | $-2.0M | $7.8B |
| Equity | $-6.6M | $75.2B |
| Net debt / equity | — | 0.69× |
| Current ratio | 0.12× | 0.84× |
| Revenue CAGR 5y | −9.5% | 8.4% |
| Profit CAGR 5y | — | −24.4% |
CVS bills 269947.4× the revenue of AIXN, and AIXN closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | AIXN | CVS |
|---|---|---|
| FY2025 | $1.5M | $402.1B |
| FY2024 | $3.8M | $372.8B |
| FY2023 | $4.1M | $357.8B |
| FY2022 | $2.7M | $322.5B |
| FY2021 | $3.1M | $292.1B |
| FY2020 | $2.5M | $268.7B |
| FY2019 | $3.4M | $256.8B |
| FY2018 | $414,281 | $194.6B |
| FY2017 | $688,095 | $184.8B |
| FY2016 | $3.1M | $177.5B |
Net income by year
Bottom line
| Fiscal year | AIXN | CVS |
|---|---|---|
| FY2025 | $-2.0M | $1.8B |
| FY2024 | $-2.8M | $4.6B |
| FY2023 | $-2.1M | $8.3B |
| FY2022 | $-6.4M | $4.3B |
| FY2021 | $-267,236 | $8.0B |
| FY2020 | $1.0M | $7.2B |
| FY2019 | $1.9M | $6.6B |
| FY2018 | $-1.3M | $-594.0M |
| FY2017 | $-4.3M | $6.6B |
| FY2016 | $-2.1M | $5.3B |
Advertisement
AdSense · Rectangle 336×280
More in this industry